RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - October 23, 2007) - Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today announced that Dr. William P. Peters, Adherex’s Chairman and CEO, will be participating in Windhover Information’s Therapeutic Area Partnerships Meeting on Thursday, October 25, 2007 at 1 pm ET at the Loews Philadelphia Hotel. ADH-1 was selected by Windhover Information and the publishers of In Vivo and Startup as one of the top 10 most interesting oncology projects available for partnering. The criteria for the top 10 selections included:
